Genmab A/S Sponsored ADR (GMAB)

Last Closing Price: 20.95 (2025-05-30)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Genmab A/S Sponsored ADR (GMAB) had Net Income of $1.14B for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$3.12B
Net Income
$1.14B
$142.82M
$2.98B
$2.15B
$971.94M
$356.85M
$1.33B
$1.33B
$1.14B
$1.14B
$1.14B
$1.14B
$971.94M
$1.03B
641.87M
646.33M
$1.77
$1.76
Balance Sheet Financials
$4.04B
$141.81M
$2.60B
$6.64B
$769.66M
--
$551.87M
$1.32B
$5.32B
$3.16B
$5.32B
661.87M
Cash Flow Statement Financials
$1.13B
$-1.44B
$-568.25M
$2.16B
$1.43B
$-726.30M
$104.55M
--
--
Fundamental Metrics & Ratios
5.25
--
--
--
--
95.42%
31.14%
31.14%
33.06%
42.57%
36.44%
$1.10B
--
--
--
0.47
15.89
3.22
113.45
21.38%
35.95%
17.12%
21.38%
$8.04
$1.70
$1.74